Form D Explorer
NBO Pharma Inc. · CIK 2103906

Report a data issueCitable research briefCompare issuerPrivate research collection

NBO Pharma Inc.

CIK 2103906 · Corporation · Inc. DELAWARE · BEDFORD, New York · Pharmaceuticals

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
2
Amendments
0
Activity
Jan 22, 2026
through Nov 9, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldJan 22, 2026 · DNov 9, 2026 · DLater minus earlier
Reported offering amount$7,640,217$7,000,000$-640,217
Reported amount sold$7,640,217$238,000$-7,402,217
Reported investor count—5—
Reported minimum investment$10,000$0$-10,000

Earlier SEC source: 0002103906-26-000001 · Later SEC source: 0002103906-26-000002

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Nov 9, 2026

Reported offering amount
$7,000,000
Reported exemptions
Rule 506(c)
Reported amount sold
$238,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (2)